No Data
No Data
Annovis Bio, Inc. (NYSE:ANVS) Surges 24%; Retail Investors Who Own 56% Shares Profited Along With Insiders
Maxim Group Maintains Annovis Bio(ANVS.US) With Hold Rating
Annovis Bio (ANVS) Receives a Hold From Maxim Group
Annovis Bio Price Target Maintained With a $21.00/Share by EF Hutton
Express News | EF Hutton Maintains Buy on Annovis Bio, Maintains $21 Price Target
Express News | Annovis Bio Shares Are Trading Higher. The Company Reported Q2 Financial Results